Autosomal genetic disease
MONDO:0000429A monogenic disease that is has material basis in a mutation in a single gene on one of the non-sex chromosomes.
Also known as: autosomal hereditary disorder, autosomal inherited disease, autosomal inherited disorder
1665 clinical trials for this condition and its sub-types, 0 tagged with Autosomal genetic disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Autosomal genetic disease
-
Autosomal recessive disease 4 trials · 994 incl. sub-types
219 sub-types
- Sickle cell disease 342 trials Sub-types →
- Cystic fibrosis 283 trials Sub-types →
- Autosomal recessive cerebellar ataxia 0 trials · 72 incl. sub-types Sub-types →
- Phenylketonuria 57 trials · 60 incl. sub-types Sub-types →
- Mismatch repair cancer syndrome 5 trials · 36 incl. sub-types Sub-types →
- Autosomal recessive limb-girdle muscular dystrophy 0 trials · 18 incl. sub-types Sub-types →
- Hearing loss, autosomal recessive 1 trial · 17 incl. sub-types Sub-types →
- Usher syndrome 14 trials · 16 incl. sub-types Sub-types →
- Netherton syndrome 15 trials
- Niemann-Pick disease type C 12 trials · 13 incl. sub-types Sub-types →
- Aicardi-Goutieres syndrome 9 trials Sub-types →
- Autosomal recessive primary microcephaly 0 trials · 8 incl. sub-types Sub-types →
- Peroxisome biogenesis disorder 4 trials · 8 incl. sub-types Sub-types →
- Bardet-Biedl syndrome 6 trials · 7 incl. sub-types Sub-types →
- RPE65-related recessive retinopathy 5 trials · 7 incl. sub-types Sub-types →
- Autosomal recessive inherited pseudoxanthoma elasticum 7 trials
- Hyperphenylalaninemia due to tetrahydrobiopterin deficiency 6 trials · 7 incl. sub-types Sub-types →
- Leukocyte adhesion deficiency 3 trials · 7 incl. sub-types Sub-types →
- Cockayne syndrome 6 trials Sub-types →
- Autosomal recessive hypophosphatemic rickets 5 trials · 6 incl. sub-types Sub-types →
- Autosomal recessive polycystic kidney disease 6 trials Sub-types →
- Thiamine-responsive megaloblastic anemia syndrome 6 trials
- Papillon-Lefevre disease 5 trials
- Shwachman-Diamond syndrome 5 trials Sub-types →
- Niemann-Pick disease type A 4 trials
- Autosomal recessive Kenny-Caffey syndrome 4 trials
- Camptodactyly-arthropathy-coxa vara-pericarditis syndrome 4 trials
- Nephronophthisis 4 trials Sub-types →
- Nephropathic cystinosis 4 trials Sub-types →
- Neuronopathy, distal hereditary motor, autosomal recessive 0 trials · 4 incl. sub-types Sub-types →
- Hutchinson-Gilford progeria syndrome 3 trials
- Sjogren-Larsson syndrome 3 trials
- Autosomal recessive severe congenital neutropenia 0 trials · 3 incl. sub-types Sub-types →
- Triple-A syndrome 3 trials
- Senior-Loken syndrome 1 trial · 2 incl. sub-types Sub-types →
- Werner syndrome 2 trials
- Autosomal recessive Alport syndrome 2 trials
- Autosomal recessive intermediate Charcot-Marie-Tooth disease 0 trials · 2 incl. sub-types Sub-types →
- Autosomal recessive osteopetrosis 0 trials · 2 incl. sub-types Sub-types →
- Autosomal recessive sideroblastic anemia 2 trials Sub-types →
- Autosomal recessive titinopathy 0 trials · 2 incl. sub-types Sub-types →
- Craniosynostosis syndrome, autosomal recessive 0 trials · 2 incl. sub-types Sub-types →
- Homocystinuria without methylmalonic aciduria 0 trials · 2 incl. sub-types Sub-types →
- Hypercalcemia, infantile 2 trials Sub-types →
- Leukoencephalopathy with calcifications and cysts 2 trials
- Odonto-onycho-dermal dysplasia 2 trials
- Proteosome-associated autoinflammatory syndrome 2 trials Sub-types →
- Alstrom syndrome 1 trial
- COFS syndrome 1 trial Sub-types →
- Ellis-van Creveld syndrome 1 trial Sub-types →
- GUCY2D-related recessive retinopathy 0 trials · 1 incl. sub-types Sub-types →
- HELIX syndrome 1 trial
- Meier-Gorlin syndrome 1 trial Sub-types →
- Niemann-Pick disease type B 1 trial
- Nijmegen breakage syndrome 1 trial
- Seckel syndrome 0 trials · 1 incl. sub-types Sub-types →
- TH-deficient dopa-responsive dystonia 1 trial
- Autosomal recessive cutis laxa type 1 1 trial Sub-types →
- Autosomal recessive ocular albinism 0 trials · 1 incl. sub-types Sub-types →
- Autosomal recessive spastic ataxia 0 trials · 1 incl. sub-types Sub-types →
- Beta-ketothiolase deficiency 1 trial
- Cartilage-hair hypoplasia 1 trial Sub-types →
- Congenital non-bullous ichthyosiform erythroderma 0 trials · 1 incl. sub-types Sub-types →
- Familial adenomatous polyposis 2 1 trial
- Growth hormone insensitivity with immune dysregulation 1, autosomal recessive 1 trial
- Human HOXA1 syndromes 1 trial Sub-types →
- Hydrocephalus, nonsyndromic, autosomal recessive 1 1 trial
- Hydrolethalus syndrome 0 trials · 1 incl. sub-types Sub-types →
- Hyper-IgM syndrome type 2 1 trial
- Immunodeficiency 31B 1 trial
- Immunodeficiency-centromeric instability-facial anomalies syndrome 1 trial Sub-types →
- Intellectual disability, autosomal recessive 0 trials · 1 incl. sub-types Sub-types →
- Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures 1 trial
- 3-M syndrome 0 trials Sub-types →
- ABCD syndrome 0 trials
- ALPL-related autosomal recessive hypophosphatasia 0 trials Sub-types →
- Behr syndrome 0 trials
- Bjornstad syndrome 0 trials
- Bloom syndrome 0 trials
- Bowen-Conradi syndrome 0 trials
- CEP164-related ciliopathy 0 trials Sub-types →
- CoQ-responsive OXPHOS deficiency 0 trials
- Donnai-Barrow syndrome 0 trials
- Donohue syndrome 0 trials
- Duane anomaly-myopathy-scoliosis syndrome 0 trials
- Ehlers-Danlos syndrome, classic-like, 2 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type 1 0 trials
- Fraser syndrome 0 trials Sub-types →
- GM3 synthase deficiency 0 trials
- Galloway-Mowat syndrome 0 trials Sub-types →
- Haim-Munk syndrome 0 trials
- IMPG1-related recessive retinopathy 0 trials Sub-types →
- Imerslund-Grasbeck syndrome type 1 0 trials
- Imerslund-Grasbeck syndrome type 2 0 trials
- Johanson-Blizzard syndrome 0 trials
- Kahrizi syndrome 0 trials
- Kilquist syndrome 0 trials
- Laron syndrome 0 trials
- Laurence-Moon syndrome 0 trials
- NAD(P)HX dehydratase deficiency 0 trials
- Naxos disease 0 trials
- Nestor-Guillermo progeria syndrome 0 trials
- Ochoa syndrome 0 trials Sub-types →
- PHARC syndrome 0 trials
- PROM1-related recessive retinopathy 0 trials Sub-types →
- Pendred syndrome 0 trials
- Perrault syndrome 0 trials Sub-types →
- Pierson syndrome 0 trials
- RP1-related recessive retinopathy 0 trials
- Rajab interstitial lung disease with brain calcifications 1 0 trials
- Roberts-SC phocomelia syndrome 0 trials
- SCN4A-related myopathy, autosomal recessive 0 trials Sub-types →
- Schwartz-Jampel syndrome 0 trials Sub-types →
- Schöpf-Schulz-Passarge syndrome 0 trials
- UV-sensitive syndrome 0 trials Sub-types →
- Uner Tan Syndrome 0 trials
- Vici syndrome 0 trials
- Warburg micro syndrome 0 trials Sub-types →
- Wolcott-Rallison syndrome 0 trials
- Achalasia microcephaly syndrome 0 trials
- Acromesomelic dysplasia 2B 0 trials
- Acrorenal syndrome, autosomal recessive 0 trials
- Alacrima, achalasia, and intellectual disability syndrome 0 trials
- Auditory neuropathy-optic atrophy syndrome 0 trials
- Autosomal recessive Ehlers-Danlos syndrome, vascular type 0 trials
- Autosomal recessive Robinow syndrome 0 trials
- Autosomal recessive amelia 0 trials
- Autosomal recessive axonal charcot-marie-tooth disease due to copper metabolism defect 0 trials
- Autosomal recessive brachyolmia 0 trials Sub-types →
- Autosomal recessive cerebral atrophy 0 trials
- Autosomal recessive cutis laxa type 2 0 trials Sub-types →
- Autosomal recessive distal renal tubular acidosis 0 trials Sub-types →
- Autosomal recessive epidermolytic ichthyosis 0 trials Sub-types →
- Autosomal recessive extra-oral halitosis 0 trials
- Autosomal recessive faciodigitogenital syndrome 0 trials
- Autosomal recessive familial Mediterranean fever 0 trials
- Autosomal recessive humeroradial synostosis 0 trials
- Autosomal recessive hydrocephalus due to congenital stenosis of aqueduct of Sylvius 0 trials
- Autosomal recessive hypohidrotic ectodermal dysplasia 0 trials Sub-types →
- Autosomal recessive multiple pterygium syndrome 0 trials Sub-types →
- Autosomal recessive omodysplasia 0 trials
- Autosomal recessive palmoplantar keratoderma and congenital alopecia 0 trials
- Autosomal recessive progressive external ophthalmoplegia 0 trials Sub-types →
- Autosomal recessive proximal renal tubular acidosis 0 trials
- Autosomal recessive spastic paraplegia type 78 0 trials
- Autosomal recessive spondylocostal dysostosis 0 trials Sub-types →
- Bifid nose, autosomal recessive 0 trials Sub-types →
- Brain small vessel disease 2B, autosomal recessive 0 trials
- Branched-chain keto acid dehydrogenase kinase deficiency 0 trials
- Brittle cornea syndrome 0 trials Sub-types →
- Camptodactyly with fibrous tissue hyperplasia and skeletal dysplasia 0 trials
- Cardiomyopathy-hypotonia-lactic acidosis syndrome 0 trials
- Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1 0 trials
- Childhood-onset autosomal recessive myopathy with external ophthalmoplegia 0 trials
- Cleft lip/palate-ectodermal dysplasia syndrome 0 trials
- Combined oxidative phosphorylation deficiency 29 0 trials
- Congenital myopathy with reduced type 2 muscle fibers 0 trials
- Congenital prothrombin deficiency 0 trials
- Congenital stationary night blindness 1G 0 trials
- Congenital vertebral-cardiac-renal anomalies syndrome 0 trials Sub-types →
- Craniometaphyseal dysplasia, autosomal recessive 0 trials
- Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies 0 trials
- Dacryocystitis-osteopoikilosis syndrome 0 trials
- De Barsy syndrome 0 trials Sub-types →
- Dyskeratosis congenita, autosomal recessive 2 0 trials
- Dyskeratosis congenita, autosomal recessive 3 0 trials
- Dyskeratosis congenita, autosomal recessive 5 0 trials
- Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 0 trials
- Eosinophil peroxidase deficiency 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 15 0 trials
- Gnb5-related intellectual disability-cardiac arrhythmia syndrome 0 trials
- Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy 0 trials
- Hair defect with photosensitivity and intellectual disability syndrome 0 trials
- Heart defects-limb shortening syndrome 0 trials
- Hyperlipoproteinemia, type 1D 0 trials
- Hypermanganesemia with dystonia 2 0 trials
- Hyperphenylalaninemia due to DNAJC12 deficiency 0 trials
- Hypertelorism, microtia, facial clefting syndrome 0 trials
- Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome 0 trials
- Hypoparathyroidism-retardation-dysmorphism syndrome 0 trials
- Ichthyosis linearis circumflexa 0 trials
- Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome 0 trials
- Inherited threoninemia 0 trials
- Isolated hyperchlorhidrosis 0 trials
- Joint laxity, short stature, and myopia 0 trials
- Leukoencephalopathy-palmoplantar keratoderma syndrome 0 trials
- Lipase deficiency, combined 0 trials
- Microcephaly and chorioretinopathy 2 0 trials
- Microcephaly, growth restriction, and increased sister chromatid exchange 2 0 trials
- Microphthalmia with limb anomalies 0 trials
- Mitochondrial complex 2 deficiency, nuclear type 3 0 trials
- Mitochondrial complex 2 deficiency, nuclear type 4 0 trials
- Mitochondrial pyruvate carrier deficiency 0 trials
- Mulibrey nanism 0 trials
- Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome 0 trials
- Myotonia congenita, autosomal recessive 0 trials
- Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities 0 trials
- Oculodentodigital dysplasia, autosomal recessive 0 trials
- Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome 0 trials
- Osteoporosis-pseudoglioma syndrome 0 trials
- Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome 0 trials
- Permanent neonatal diabetes mellitus 1 0 trials
- Persistent hyperplastic primary vitreous, autosomal recessive 0 trials
- Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome 0 trials
- Polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly 0 trials Sub-types →
- Pseudo-TORCH syndrome 0 trials Sub-types →
- Pseudohypoaldosteronism, type IB2, autosomal recessive 0 trials
- Pseudohypoaldosteronism, type IB3, autosomal recessive 0 trials
- Rapadilino syndrome 0 trials
- Scapuloperoneal spinal muscular atrophy, autosomal recessive 0 trials
- Severe combined immunodeficiency due to CARMIL2 deficiency 0 trials
- Short-rib thoracic dysplasia 9 with or without polydactyly 0 trials
- Skin fragility-woolly hair-palmoplantar keratoderma syndrome 0 trials
- Spastic paraplegia 18b, autosomal recessive 0 trials
- Spastic paraplegia 30B, autosomal recessive 0 trials
- Spondyloepimetaphyseal dysplasia with joint laxity, type 3 0 trials
- Spondyloepiphyseal dysplasia tarda, autosomal recessive 0 trials
- Temtamy preaxial brachydactyly syndrome 0 trials
-
Autosomal dominant disease 0 trials · 699 incl. sub-types
192 sub-types
- Neurofibromatosis 19 trials · 94 incl. sub-types Sub-types →
- Lynch syndrome 81 trials · 83 incl. sub-types Sub-types →
- Autosomal dominant polycystic kidney disease 59 trials Sub-types →
- Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome 53 trials
- Tuberous sclerosis 41 trials · 44 incl. sub-types Sub-types →
- Hereditary breast ovarian cancer syndrome 35 trials · 38 incl. sub-types Sub-types →
- Early-onset autosomal dominant Alzheimer disease 31 trials · 37 incl. sub-types Sub-types →
- Hereditary hemorrhagic telangiectasia 34 trials Sub-types →
- Multiple endocrine neoplasia type 1 34 trials
- Autosomal dominant cerebellar ataxia 11 trials · 33 incl. sub-types Sub-types →
- Von Hippel-Lindau disease 27 trials
- Intellectual disability, autosomal dominant 0 trials · 23 incl. sub-types Sub-types →
- Marfan syndrome 21 trials Sub-types →
- Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 19 trials
- Li-Fraumeni syndrome 16 trials
- NOTCH1-related AOS spectrum disorder 0 trials · 16 incl. sub-types Sub-types →
- Cowden disease 11 trials Sub-types →
- Autosomal dominant hypocalcemia 9 trials · 10 incl. sub-types Sub-types →
- Peutz-Jeghers syndrome 9 trials
- Neurohypophyseal diabetes insipidus 9 trials
- PTEN hamartoma tumor syndrome 6 trials · 8 incl. sub-types Sub-types →
- Costello syndrome 7 trials
- Autosomal dominant medullary cystic kidney disease with or without hyperuricemia 7 trials Sub-types →
- Loeys-Dietz syndrome 6 trials Sub-types →
- Autosomal dominant optic atrophy 6 trials Sub-types →
- Melanoma, cutaneous malignant, susceptibility to, 2 6 trials
- Nevoid basal cell carcinoma syndrome 5 trials Sub-types →
- Carney complex 4 trials Sub-types →
- Crouzon syndrome-acanthosis nigricans syndrome 4 trials
- Multiple endocrine neoplasia type 2A 4 trials
- Muscular dystrophy, limb-girdle, autosomal dominant 0 trials · 4 incl. sub-types Sub-types →
- Piebaldism 4 trials
- Muckle-Wells syndrome 3 trials
- Noonan syndrome with multiple lentigines 3 trials Sub-types →
- Autosomal dominant Emery-Dreifuss muscular dystrophy 0 trials · 3 incl. sub-types Sub-types →
- Autosomal dominant intermediate Charcot-Marie-Tooth disease 0 trials · 3 incl. sub-types Sub-types →
- Autosomal dominant polycystic liver disease 3 trials Sub-types →
- Hyper-IgE recurrent infection syndrome 1, autosomal dominant 3 trials
- Birt-Hogg-Dube syndrome 2 trials Sub-types →
- Brooke-Spiegler syndrome 0 trials · 2 incl. sub-types Sub-types →
- Muir-Torre syndrome 2 trials
- Autosomal dominant nonsyndromic hearing loss 1 trial · 2 incl. sub-types Sub-types →
- Autosomal dominant progressive external ophthalmoplegia 1 trial · 2 incl. sub-types Sub-types →
- Autosomal dominant vibratory urticaria 2 trials
- Hereditary retinoblastoma 2 trials
- Multiple endocrine neoplasia type 2B 2 trials
- Nail-patella syndrome 2 trials
- Denys-Drash syndrome 1 trial
- Duane-radial ray syndrome 1 trial Sub-types →
- EEC syndrome 1 trial Sub-types →
- Timothy syndrome 1 trial Sub-types →
- Waardenburg syndrome 1 trial Sub-types →
- Brain small vessel disease 2A, autosomal dominant 1 trial
- Cherubism 1 trial Sub-types →
- Colorectal cancer, hereditary nonpolyposis, type 6 1 trial
- Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A 1 trial
- Gastric adenocarcinoma and proximal polyposis of the stomach 1 trial
- Macrocephaly-autism syndrome 1 trial
- Microcephalic osteodysplastic dysplasia, Saul-Wilson type 1 trial
- Multiple cutaneous and mucosal venous malformations 1 trial
- Proximal symphalangism 1 trial Sub-types →
- Trichorhinophalangeal syndrome type II 1 trial
- ADULT syndrome 0 trials
- ALG8-related autosomal dominant polycystic kidney and/or liver disease 0 trials
- ALPL-related autosomal dominant hypophosphatasia 0 trials Sub-types →
- Alagille syndrome due to a JAG1 point mutation 0 trials
- BMPR1A-related juvenile polyposis syndrome 0 trials
- Beare-Stevenson cutis gyrata syndrome 0 trials
- Birk-Barel syndrome 0 trials
- Charcot-Marie-Tooth disease, demyelinating, type 1G 0 trials
- Charcot-Marie-tooth disease, axonal, type 2DD 0 trials
- Coffin-Siris syndrome 1 0 trials
- Delpire-McNeill syndrome 0 trials
- Ehlers-Danlos syndrome, classic type 0 trials Sub-types →
- FLNB-associated autosomal dominant filamin related bone disorder 0 trials Sub-types →
- Feingold syndrome 0 trials Sub-types →
- Flynn-Aird syndrome 0 trials
- Frasier syndrome 0 trials
- GUCY2D-related dominant retinopathy 0 trials Sub-types →
- Holt-Oram syndrome 0 trials Sub-types →
- Houge-Janssens syndrome 2 0 trials
- IMPG1-related dominant retinopathy 0 trials Sub-types →
- KINSSHIP syndrome 0 trials
- LADD syndrome 0 trials Sub-types →
- LAMA5-related multisystemic syndrome 0 trials
- MAX-related tumor predisposition 0 trials
- MYH10-related neurodevelopmental disorder with congenital anomalies 0 trials
- NOG-related symphalangism spectrum disorder 0 trials Sub-types →
- PCWH syndrome 0 trials
- PROM1-related dominant retinopathy 0 trials Sub-types →
- PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome 0 trials Sub-types →
- Pelger-Huet anomaly 0 trials
- Pilarowski-Bjornsson syndrome 0 trials
- RP1-related dominant retinopathy 0 trials
- RPE65-related dominant retinopathy 0 trials Sub-types →
- Rapp-Hodgkin syndrome 0 trials
- TMEM127-related tumor predisposition 0 trials
- Townes-Brocks syndrome 0 trials Sub-types →
- Treacher-Collins syndrome 0 trials Sub-types →
- Acroosteolysis dominant type 0 trials
- Amelogenesis imperfecta type 1B 0 trials
- Arthrogryposis, distal, type 2B2 0 trials
- Arthrogryposis, distal, type 2B3 0 trials
- Autosomal dominant Aarskog syndrome 0 trials
- Autosomal dominant Alport syndrome 0 trials
- Autosomal dominant Ehlers-Danlos syndrome, vascular type 0 trials
- Autosomal dominant Kenny-Caffey syndrome 0 trials
- Autosomal dominant Robinow syndrome 0 trials Sub-types →
- Autosomal dominant brachyolmia 0 trials
- Autosomal dominant cataract 0 trials Sub-types →
- Autosomal dominant centronuclear myopathy 0 trials
- Autosomal dominant chondrodysplasia punctata 0 trials Sub-types →
- Autosomal dominant coarctation of aorta 0 trials
- Autosomal dominant complex spastic paraplegia 0 trials Sub-types →
- Autosomal dominant cutis laxa 0 trials Sub-types →
- Autosomal dominant distal myopathy 0 trials Sub-types →
- Autosomal dominant distal renal tubular acidosis 0 trials
- Autosomal dominant epidermolytic ichthyosis 0 trials Sub-types →
- Autosomal dominant hypohidrotic ectodermal dysplasia 0 trials Sub-types →
- Autosomal dominant hypophosphatemic rickets 0 trials
- Autosomal dominant ichthyosis vulgaris 0 trials Sub-types →
- Autosomal dominant keratitis 0 trials
- Autosomal dominant keratitis-ichthyosis-hearing loss syndrome 0 trials
- Autosomal dominant myoglobinuria 0 trials
- Autosomal dominant nebulin-related myopathy 0 trials
- Autosomal dominant oculocutaneous albinism 0 trials
- Autosomal dominant omodysplasia 0 trials
- Autosomal dominant osteopetrosis 0 trials Sub-types →
- Autosomal dominant popliteal pterygium syndrome 0 trials
- Autosomal dominant primary microcephaly 0 trials Sub-types →
- Autosomal dominant proximal renal tubular acidosis 0 trials
- Autosomal dominant rhegmatogenous retinal detachment 0 trials
- Autosomal dominant severe congenital neutropenia 0 trials Sub-types →
- Autosomal dominant sideroblastic anemia 0 trials
- Autosomal dominant spastic ataxia 0 trials Sub-types →
- Autosomal dominant spondylocostal dysostosis 0 trials
- Autosomal dominant titinopathy 0 trials Sub-types →
- Blepharocheilodontic syndrome 0 trials Sub-types →
- Blepharophimosis, ptosis, and epicanthus inversus syndrome 0 trials Sub-types →
- Branchio-oto-renal syndrome 0 trials Sub-types →
- Branchiooculofacial syndrome 0 trials
- Calcaneonavicular coalition 0 trials
- Cataract-aberrant oral frenula-growth delay syndrome 0 trials
- Cochleosaccular degeneration-cataract syndrome 0 trials
- Colorectal cancer, hereditary nonpolyposis, type 7 0 trials
- Congenital stationary night blindness autosomal dominant 3 0 trials
- Diffuse nonepidermolytic palmoplantar keratoderma 0 trials
- Distal arthrogryposis type 2B1 0 trials
- Dyskeratosis congenita, autosomal dominant 2 0 trials
- Dyskeratosis congenita, autosomal dominant 3 0 trials
- Dyskeratosis congenita, autosomal dominant 6 0 trials
- Epidermolysis bullosa simplex 6, generalized, with scarring and hair loss 0 trials
- Familial antiphospholipid syndrome 0 trials
- Fatty acyl-CoA reductase 1 upregulation 0 trials
- Generalized juvenile polyposis/juvenile polyposis coli 0 trials
- Hand-foot-genital syndrome 0 trials
- Heart-hand syndrome, Slovenian type 0 trials
- Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome 0 trials
- Hyperkeratosis-hyperpigmentation syndrome 0 trials
- Hypopigmentation-punctate palmoplantar keratoderma syndrome 0 trials
- Inclusion body myopathy and brain white matter abnormalities 0 trials
- Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism 0 trials
- Intellectual disability, autosomal dominant 14 0 trials
- Intellectual disability, autosomal dominant 15 0 trials
- Intellectual disability, autosomal dominant 16 0 trials
- Intellectual disability, autosomal dominant 29 0 trials
- Intellectual disability, autosomal dominant 30 0 trials
- Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency 0 trials
- Isolated congenital adermatoglyphia 0 trials
- Juvenile cataract-microcornea-renal glucosuria syndrome 0 trials
- Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome 0 trials
- Mandibulofacial dysostosis-microcephaly syndrome 0 trials
- Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability 0 trials
- Monilethrix 0 trials Sub-types →
- Multiple endocrine neoplasia type 4 0 trials
- Neuronopathy, distal hereditary motor, autosomal dominant 0 trials Sub-types →
- Palmoplantar keratoderma-spastic paralysis syndrome 0 trials
- Pheochromocytoma/paraganglioma syndrome 1 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 3 0 trials
- Pheochromocytoma/paraganglioma syndrome 4 0 trials
- Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome 0 trials
- Renal coloboma syndrome 0 trials
- Retinoschisis, autosomal dominant 0 trials
- Scapuloperoneal spinal muscular atrophy, autosomal dominant 0 trials
- Severe achondroplasia-developmental delay-acanthosis nigricans syndrome 0 trials
- Spastic paraplegia 30A, autosomal dominant 0 trials
- Spondyloepimetaphyseal dysplasia with multiple dislocations 0 trials
- Spondyloepiphyseal dysplasia tarda, autosomal dominant 0 trials
- Thanatophoric dysplasia type 1 0 trials
- Thrombophilia due to protein S deficiency, autosomal dominant 0 trials
- Trichorhinophalangeal syndrome type I 0 trials
-
Congenital factor XII deficiency 1 trial
-
Septooptic dysplasia 1 trial
2 sub-types
- Congenital absence of septum pellucidum 0 trials
- Pagon stephan syndrome 0 trials
-
Weill-Marchesani syndrome 0 trials
4 sub-types
- Weill-Marchesani 4 syndrome, recessive 0 trials
- Weill-Marchesani syndrome 1 0 trials
- Weill-Marchesani syndrome 2, dominant 0 trials
- Weill-Marchesani syndrome 3 0 trials
-
Brachydactyly-syndactyly syndrome 0 trials
-
Congenital factor XI deficiency 0 trials
Most studied deeper sub-types
-
Engineered immune cells take aim at Hard-to-Treat cervical cancer
Disease control Stopped earlyThis trial investigates whether specially engineered immune cells (CAR-T cells) can safely treat advanced or recurrent cervical cancer. The cells are designed to recognize and attack cancer cells that carry certain markers like GD2 or Mesothelin. The study involves 20 adults with…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Immune cells take on nerve tumors: new trial launches
Disease control Stopped earlyThis early-stage trial is testing whether specially engineered immune cells (called CAR-T and CTL cells) and a dendritic cell vaccine can safely treat people with neurofibromatosis or schwannomatosis, conditions that cause nerve tumors. The study will enroll 100 participants aged…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Experimental drug REC-2282 targets NF2 brain tumors in early trial
Disease control Stopped earlyThis study tested a drug called REC-2282 in people aged 12 and older with progressive meningiomas (brain tumors) linked to NF2 gene mutations. Participants took the drug or a placebo three times a week in cycles. The goal was to see if the drug could slow tumor growth. The trial …
Phase 2/3 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a new nucleotide analogue boost cancer treatment?
Disease control Stopped earlyThis trial is testing an experimental drug called NUC-3373, a nucleotide analogue, in combination with standard cancer drugs for people with advanced solid tumors. The study has two parts: one combining NUC-3373 with pembrolizumab, and the other combining it with docetaxel. The g…
Phase 1/2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a gel cut down on skin cancer surgeries? new trial investigates
Disease control Stopped earlyThis trial tests a gel called patidegib applied to the face twice daily for 9 months in people who develop many basal cell carcinomas (a common skin cancer) but do not have Gorlin syndrome. The goal is to see if the gel reduces the number of new skin cancers that would normally r…
Phase 2 • Sponsor: Sol-Gel Technologies, Ltd. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Light-Activated cream could slow growth of NF1 skin tumors
Disease control Stopped earlyThis trial tests whether a light-activated cream (Levulan Kerastick) followed by red light therapy can slow the growth of benign skin tumors called neurofibromas in people with neurofibromatosis type 1 (NF1). About 30 participants aged 14 and older with superficial tumors on the …
Phase 2 • Sponsor: Donald Basel • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Experimental Friedreich's ataxia drug tested in kids – but trial halted early
Disease control Stopped earlyThis early-stage trial tested a drug called nomlabofusp (CTI-1601) in 18 adolescents and children with Friedreich's ataxia, a rare genetic disease that affects movement and coordination. The goal was to check safety and how the body processes the drug. However, the study was term…
Phase 1 • Sponsor: Larimar Therapeutics, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Real-World study tracks Selumetinib's impact on NF1 tumors in children
Disease control Stopped earlyThis study observes children aged 3 to 18 with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas and are starting treatment with selumetinib. Researchers will track how well the drug shrinks or stabilizes tumors, how long patients stay on tre…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Experimental vaccine aims to shrink colorectal tumors before surgery
Disease control Stopped earlyThis trial tested a vaccine called PD1-Vaxx given before surgery to people with a specific type of colorectal cancer (MSI-high). The goal was to see if the vaccine could shrink tumors, measured by how many cancer cells remained after treatment. Only 3 people took part, and the st…
Phase 2 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a common blood pressure drug shrink kidney tumors?
Disease control Stopped earlyThis pilot study tested whether propranolol, a beta-blocker, could shrink or stabilize kidney angiomyolipomas in people with tuberous sclerosis. Only 2 participants were enrolled before the trial was terminated, so the results are very limited. The goal was to find a less invasiv…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a common laxative soothe gut inflammation in cystic fibrosis?
Disease control Stopped earlyThis phase 2 trial investigates whether polyethylene glycol (a laxative) can reduce intestinal inflammation in children with cystic fibrosis. The study includes children aged 4 to 17 with cystic fibrosis and pancreatic insufficiency who have elevated fecal calprotectin (a marker …
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Sickle cell transplant study halted after just one patient
Disease control Stopped earlyThis study tested a drug called siplizumab alongside a stem cell transplant for people with severe sickle cell disease. The goal was to see if it could prevent the body from rejecting the new cells and reduce a serious side effect called graft-versus-host disease. Only one person…
Phase 1/2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Experimental cancer drug study halted early
Disease control Stopped earlyThis early-stage study tested a new drug called PF-07284892, alone or with other medicines, in people with advanced solid tumors that had specific genetic changes. The goal was to find the safest dose and check for side effects. The study was stopped early, so results are limited…
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Experimental drug for rare skin disease fails to reach goal
Disease control Stopped earlyThis early-stage trial tested a drug called DS-2325a in 9 adults with Netherton syndrome, a rare genetic condition causing severe skin redness, scaling, and allergies. The study aimed to check safety and whether the drug could help control the disease. However, the trial was term…
Phase 1/2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New cocktail of cancer drugs tested in desperate cases
Disease control Stopped earlyThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Experimental triple therapy for advanced cancers shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested the drug plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combination was safe and could shrink…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Cystic fibrosis drug repurposed: can a liver medication fix lung function?
Disease control Stopped earlyThis early-phase trial tested whether glycerol phenylbutyrate (Ravicti), a drug already used for urea cycle disorders, could help restore chloride transport in the nasal cells of adults with cystic fibrosis. The study enrolled 16 participants and compared low-dose Ravicti to a pl…
Phase 1/2 • Sponsor: National Jewish Health • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Gene therapy trial for cystic fibrosis halted early
Disease control Stopped earlyThis study tested a single dose of an inhaled gene therapy called BI 3720931 in adults with cystic fibrosis who cannot take standard CFTR modulator drugs. The trial was in two phases and included only 5 participants. It was terminated early, so we do not have full results on safe…
Phase 1/2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Experimental drug TPN-101 tested in rare childhood brain disease
Disease control Stopped earlyThis study tested a drug called TPN-101 (censavudine) in people with Aicardi-Goutières syndrome, a rare genetic disorder that causes severe brain inflammation. The trial enrolled only 4 participants and aimed to see if the drug could reduce immune system overactivity and check fo…
Phase 2 • Sponsor: Transposon Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Sickle cell drug safety trial ends early
Disease control Stopped earlyThis study looked at the long-term safety of the drug osivelotor in people with sickle cell disease who had already taken it in an earlier trial. The goal was to track side effects and blood changes over time. However, the study was terminated early, so the full safety picture is…
Phase 2/3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Hope for rare skin disease: new drug shows promise in trial
Disease control Stopped earlyThis study tested a medicine called spesolimab for people with Netherton syndrome, a rare genetic skin condition causing severe redness and scaling. About 43 people aged 12 and older took part, receiving either the drug or a placebo. The goal was to see if spesolimab could reduce…
Phase 2/3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New PKU formula shows promise in managing blood levels
Disease control Stopped earlyThis study tested a new amino acid formula called PKU GOLIKE in people aged 16 and older with phenylketonuria (PKU). The goal was to see if it could better control daily swings in blood phenylalanine levels compared to standard treatment. The study was stopped early, so results a…
Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Sickle cell drug trial in kids halted early – but data may still help
Disease control Stopped earlyThis study tested a daily pill called voxelotor in children aged 2 to 14 with sickle cell disease who had slightly abnormal blood flow in the brain. The goal was to see if the drug could improve that blood flow and reduce stroke risk. The trial was stopped early, but the results …
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental kidney cancer drug trial halted early
Disease control Stopped earlyThis early-stage trial tested a new drug called DFF332, which targets a protein (HIF2α) that helps some cancers grow. The study included 40 adults with advanced clear cell renal cell carcinoma or other cancers with specific gene changes. DFF332 was tested alone and in combination…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Virus therapy fails to advance in colorectal cancer trial
Disease control Stopped earlyThis study tested a new approach using a virus that attacks cancer cells (oncolytic immunotherapy) along with two standard drugs (atezolizumab and bevacizumab) in people with advanced colorectal cancer that had stopped responding to other treatments. The trial was stopped early a…
Phase 2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Cancer drug may tame sickle cell pain, early study hints
Disease control Stopped earlyThis small pilot study tested whether imatinib, a drug used for certain cancers, could reduce painful blockages in blood vessels (vaso-occlusive crises) in people with sickle cell anemia. Seven participants aged 18–25 took the drug for 6 months while researchers measured changes …
Phase 1/2 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Old arthritis drug tested against rare tumor syndrome – but trial stalls
Disease control Stopped earlyThis study tested leflunomide, a drug used for rheumatoid arthritis, in 3 adults with MEN1 syndrome—a genetic condition that raises the risk of multiple tumors. The goal was to see if 6 months of daily leflunomide could shrink or stabilize tumors. However, the trial was terminate…
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Colon cancer combo trial ends early – only one patient enrolled
Disease control Stopped earlyThis study tested a combination of two drugs (regorafenib and pembrolizumab) for people with a specific type of advanced colorectal cancer called MSI-H. The goal was to see if the combination worked better than pembrolizumab alone. The trial was stopped early after enrolling only…
Phase 2 • Sponsor: Anwaar Saeed • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Sickle cell drug candidate tested in first human trial – but study halted early
Disease control Stopped earlyThis was a first-in-human study testing a single dose of an experimental drug called GSK4172239D in 11 people with sickle cell disease. The main goals were to check safety and how the drug moves through the body. The study was terminated early, so results are limited.
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental gene therapy for rare muscle disease shows early promise but study halted
Disease control Stopped earlyThis study tested a gene therapy called SRP-9003 for people with limb-girdle muscular dystrophy type 2E (LGMD2E), a rare genetic disease that causes muscle weakness. The treatment aimed to deliver a working gene to muscle cells to help them produce a missing protein. Only 6 peopl…
Phase 1/2 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Sickle cell gene therapy trial halted after just 4 patients
Disease control Stopped earlyThis early-phase trial tested a gene-edited stem cell product called OTQ923 in 4 people with severe sickle cell disease. The goal was to boost fetal hemoglobin to reduce painful crises and other complications. The study was terminated early, so we have limited data on safety and …
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Sickle cell drug oxbryta tracked in real life: what happened?
Disease control Stopped earlyThis study followed 265 people with sickle cell disease who were taking Oxbryta (voxelotor) as part of their normal care. Researchers wanted to see how the drug affected hemoglobin levels, sickle cell complications, and overall health over up to 5 years. The study was observation…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Cystic fibrosis drug trial halted early
Disease control Stopped earlyThis study tested an experimental drug called ARO-ENaC in healthy volunteers and people with cystic fibrosis. The goal was to see if it is safe and helps lung function. The trial was stopped early, so results are limited.
Phase 1/2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Sickle cell drug inclacumab safety checked in long-term study
Disease control Stopped earlyThis study looks at the long-term safety of inclacumab in people with sickle cell disease who have already taken the drug in a previous study. It tracks side effects and how often pain crises occur. The goal is to see if long-term use is safe and helps control the disease.
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Sickle cell drug voxelotor tested for brain benefits in kids – study cut short
Disease control Stopped earlyThis study looked at whether voxelotor, a daily pill for sickle cell anemia, can improve blood flow and oxygen supply to the brain in children. The trial planned to enroll 22 participants aged 4 to 30 years with a severe form of sickle cell disease. However, the study was termina…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Experimental drug roscovitine tested in cystic fibrosis patients
Disease control Stopped earlyThis phase II trial tested an experimental drug called roscovitine in 36 adults with cystic fibrosis who have a common genetic mutation and a chronic lung infection. The goal was to check the safety of different doses given in short cycles. The study was terminated early, so its …
Phase 2 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Experimental drug AR-42 tested on brain tumors – early results uncertain
Disease control Stopped earlyThis early-phase trial tested the drug AR-42 in 7 adults with vestibular schwannoma or meningioma brain tumors who were already scheduled for surgery. Participants took AR-42 pills for about 3 weeks before their operation. The main goal was to see if the drug could lower a protei…
Early phase 1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Growth hormone trial for CF wasting halted early
Disease control Stopped earlyThis small Phase 1 trial tested growth hormone in 5 adults with cystic fibrosis who were underweight. The goal was to see if the hormone could help them gain weight and muscle, improve their quality of life, and monitor effects on lung function and diabetes. The study was termina…
Phase 1 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Promising cream for rare skin condition falls short in early trial
Disease control Stopped earlyThis study tested a sirolimus cream (0.2% and 0.4%) applied daily for 12 weeks to treat facial angiofibromas in children aged 2-21 with tuberous sclerosis complex. The goal was to see if the cream could safely reduce the size and redness of these skin growths. The trial was termi…
Phase 2 • Sponsor: Aucta Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Sickle cell drug voxelotor tested for Long-Term safety
Disease control Stopped earlyThis study looked at the long-term safety of voxelotor (a daily pill) in 179 people with sickle cell disease who had already taken it in a previous trial. Participants continued taking the drug and were monitored for side effects and complications like pain crises. The trial was …
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Sickle cell drug voxelotor tested for Long-Term safety – but trial ends early
Disease control Stopped earlyThis study looked at the long-term safety of the drug voxelotor in 162 people with sickle cell disease who had already taken it in earlier trials. Everyone received voxelotor once daily. The main goal was to track side effects. The trial was terminated early, so the full safety p…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Experimental cell therapy targets deadly childhood brain cancer
Disease control Stopped earlyThis early-phase trial tested a new immunotherapy approach for children with DIPG, a rare and aggressive brain stem tumor. After standard radiation and chemotherapy, patients received special vaccines and immune cells designed to attack the tumor. The study was small (11 particip…
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental seizure drug tested in rare genetic disorder
Disease control Stopped earlyThis phase 3 study tested the drug ganaxolone as an add-on treatment for seizures in children and adults with tuberous sclerosis complex (TSC). The trial was open-label, meaning everyone received the drug, and it included 117 people who had previously been in related studies. The…
Phase 3 • Sponsor: Marinus Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Kidney drug trial halted: venglustat fails to slow disease
Disease control Stopped earlyThis study looked at whether taking venglustat earlier versus later could help people with a fast-progressing form of polycystic kidney disease. The trial was stopped early because the main study found the drug did not work well enough. Only 24 people took part, so no clear concl…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 18:08 UTC
-
Experimental gene therapy for rare muscle disease tested in just 2 people
Disease control Stopped earlyThis was a very early (Phase 1) study testing a gene therapy called SRP-6004 for people with limb girdle muscular dystrophy type 2B/R2, a rare muscle-weakening disease. The goal was to see if a single IV infusion of the therapy is safe and can help the body produce a missing prot…
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:20 UTC
-
Experimental gene therapy tested for rare muscular dystrophy
Disease control Stopped earlyThis early-stage trial tested a gene therapy called SRP-9004 in just 4 people with limb girdle muscular dystrophy type 2D/R3, a rare muscle-weakening disease. The main goal was to check safety, not effectiveness. The study was terminated early, so results are limited.
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:47 UTC
-
Breathing machine may ease lung risk for kids with sickle cell
Prevention Stopped earlyThis study tested whether a non-invasive breathing machine (ventilation) could prevent acute chest syndrome, a serious lung complication, in children with sickle cell disease who were hospitalized for severe pain. The standard prevention is spirometry, which requires active deep …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Could a High-Fat diet boost brain health in early Alzheimer's?
Symptom relief Stopped earlyThis study looks at whether a ketogenic diet (high-fat, low-carb) is practical and safe for people with early-stage Alzheimer's disease over one year. The diet may provide an alternative energy source for the brain and reduce inflammation. Researchers will track diet adherence, b…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Could a common heart drug tame nosebleeds in rare disease?
Symptom relief Stopped earlyThis study tested whether propranolol, a beta-blocker usually used for heart conditions, can reduce nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT), a genetic disorder that causes abnormal blood vessels. Fifteen adults with HHT took either propranolol or a p…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Nasal spray could replace needles for sickle cell pain emergencies
Symptom relief Stopped earlyThis study tested a nasal spray containing a strong painkiller (sufentanil) for adults with sickle cell disease experiencing a painful crisis. The goal was to see if it could provide faster relief than the standard gas mixture (EMONO) before giving morphine through an IV. The tri…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Mindfulness may ease anxiety for heart device patients
Symptom relief Stopped earlyThis study tested whether a mindfulness program (including meditation, body scans, and gentle yoga) could help people with implanted heart devices like ICDs or pacemakers feel less anxious, stressed, and depressed. The study planned to enroll 34 adults who had recently received s…
Sponsor: Chien Chih-Yin • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
CBD study for baby seizures halted early
Symptom relief Stopped earlyThis study tested a cannabidiol (CBD) oral solution in children under 2 years old with tuberous sclerosis complex, Dravet syndrome, or Lennox-Gastaut syndrome who had uncontrolled seizures. The goal was to see if CBD is safe and can reduce seizures. However, the study was termina…
Phase 3 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Scientists dive into rare cholesterol disorders to uncover clues
Knowledge-focused Stopped earlyThis study looks at rare genetic disorders where the body can't make cholesterol properly, which can cause birth defects and learning problems. Researchers collect blood, urine, and tissue samples from affected people and their families to learn more about these conditions. The g…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Rare skin disease study seeks to understand netherton syndrome
Knowledge-focused Stopped earlyThis study aimed to collect real-world data on Netherton Syndrome, a rare genetic skin disorder. Researchers planned to follow 4 participants over 52 weeks, measuring skin severity and other symptoms. The study was terminated early, so results are limited.
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New sickle cell drug pociredir enters early human testing
Knowledge-focused Stopped earlyThis early-stage study is testing a new drug called pociredir in 24 adults with sickle cell disease. Researchers want to see how the drug moves through the body and whether taking it with food changes its effects. The goal is to gather safety and dosing information, not to treat …
Phase 1 • Sponsor: Fulcrum Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists dive into cells to unravel costello Syndrome's secrets
Knowledge-focused Stopped earlyThis study collects small skin samples from children aged 2 to 17 with Costello syndrome or a related condition. Researchers will analyze the cells to understand how a mutation in the HRAS gene affects energy use and mitochondria. The goal is to learn more about the disease's und…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
MRI vs. CT: a safer way to track cystic fibrosis lung health?
Knowledge-focused Stopped earlyThis study looked at whether MRI scans can detect changes in the lungs of people with cystic fibrosis as well as CT scans do. CT scans use radiation, so finding a reliable alternative like MRI could mean safer monitoring over time. The study included 212 patients aged 8 and older…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
PKU diet in childhood may shape adult IQ, study finds
Knowledge-focused Stopped earlyThis study looks at adults with phenylketonuria (PKU) who were diagnosed as newborns and treated with a special diet. Researchers want to see if how long and how strictly they followed the diet as children affects their intelligence (IQ) as adults. The goal is to use this informa…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Cystic fibrosis infection study halted early
Knowledge-focused Stopped earlyThis study aimed to find out how common non-tuberculous mycobacteria (NTM) infections are in people with cystic fibrosis in France. Researchers collected sputum and blood samples from 848 participants to test for NTM using culture and a new blood test. The study was terminated ea…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
Cystic fibrosis study aims to build a research database, not test a cure
Knowledge-focused Stopped earlyThis study is for people with cystic fibrosis and their family members. Its goal is to collect medical information and biological samples during regular clinic visits. These will be stored and used by researchers to learn more about how cystic fibrosis affects the body and how it…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Drug interaction study for radiprodil halted early
Knowledge-focused Stopped earlyThis early-stage study looked at how two common drugs (carbamazepine and itraconazole) change the levels of radiprodil in the blood of 30 healthy adults. The goal was to understand safety and dosing for future use in neurological conditions like tuberous sclerosis. However, the s…
Phase 1 • Sponsor: GRIN Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
AI stethoscope could spot lung disease patterns
Knowledge-focused Stopped earlyThis study tested whether artificial intelligence can detect and classify abnormal lung sounds in people with cystic fibrosis, COPD, or pulmonary fibrosis. Researchers recorded lung sounds with an electronic stethoscope during routine checkups and analyzed them using AI. The goal…
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Cystic fibrosis gene fix tested in nasal cells
Knowledge-focused Stopped earlyThis study aimed to see if a new type of genetic therapy could fix a specific problem in the CFTR gene that causes cystic fibrosis. Researchers took nasal and rectal cell samples from 16 patients and tested the therapy in the lab. The study was terminated early, so we don't have …
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:40 UTC